About
Qnity is a Brazilian deep-tech startup based in São Paulo that develops quantum-electrochemical devices for ultra-sensitive drug discovery and molecular screening. Its quantum-enhanced electrochemical sensors detect molecular binding events and chemical reactions at high sensitivity, with applications in pharmaceutical development, molecular affinity assays, and biologics screening. It serves the pharmaceutical and biotechnology industries in Brazil and Latin America. In 2025, Qnity won the World Economic Forum's Quantum for Sustainability challenge and exhibited at the BIO International Convention 2025. It is part of Brazil's quantum ecosystem alongside the FAPESP QuTIa program, which launched in December 2024 with a BRL 31M budget.
Quantum Specifications
| Quantum Focus | hardware |
Backed By
Lakestar
Lightspeed Venture Partners
Quantum Coast Capital
Type One Ventures
Trumpf Venture
Gic Government Of Singapore Investment Corporation
Hercules Capital
Inven Capital
Frequently Asked Questions
Qnity is a Brazilian deep-tech startup based in São Paulo that develops quantum-electrochemical devices for ultra-sensitive drug discovery and molecular screening. Its quantum-enhanced electrochemical sensors detect molecular binding events and chemical reactions at high sensitivity, with applications in pharmaceutical development, molecular affinity assays, and biologics screening. It serves the pharmaceutical and biotechnology industries in Brazil and Latin America.
In 2025, Qnity won the ...
Qnity is headquartered in São Paulo, Brazil.
Qnity was founded in 2022.
Qnity operates in the following sectors: quantum sensing, quantum hardware, drug discovery.
